SFX by Ex Libris Inc.

Title:	Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Source:	Science [0036-8075] Masuda, T yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Raja, J V. "Recent advances in gene therapy for thalassemia." Journal of Pharmacy and Bioallied Sciences 4.3 (2012): 194-201.
description	2.	Wilkinson, K. "Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease." Transfusion 52.2 (2012): 381-388.
description	3.	Chatterjee, S. "Target-Mediated Protection of Endogenous MicroRNAs in C. elegans." Developmental cell 20.3 (2011): 388-396.
description	4.	Bauer, Daniel E. "Update on fetal hemoglobin gene regulation in hemoglobinopathies." Current opinion in pediatrics 23.1 (2010): 1-8.
description	5.	Sankaran, Vijay G. "Transcriptional silencing of fetal hemoglobin by BCL11A." Annals of the New York Academy of Sciences 1202.1 (2010): 64-68.
description	6.	Sankaran, V. "Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A." Science 322.5909 (2008): 1839-1842.
description	7.	Sankaran, Vijay G. "Developmental and species-divergent globin switching are driven by BCL11A." Nature 460.7259 (2009): 1093-7.
description	8.	Lettre, G. "DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease." Proceedings of the National Academy of Sciences of the United States of America 105.33 (2008): 11869-74.
description	9.	Thein, Swee L. "Discovering the genetics underlying foetal haemoglobin production in adults." British journal of haematology 145.4 (2009): 455-467.
description	10.	SL, T. "Control of fetal hemoglobin: new insights emerging from genomics and clinical implications." Human Molecular Genetics 18.R2 (2009): -23.
description	11.	Kobayashi, H. "Epigenetic regulation of open chromatin in pluripotent stem cells." Translational Research 165.1 (2014): 115-125.
description	12.	Dong, A. "Gene therapy for hemoglobinopathies: progress and challenges." Translational Research 161.4 (2013): 293-306.
description	13.	Troxler, H. "Advances in hemoglobinopathy detection and identification." Adv Clin Chem 57 (2012): 1-28.
description	14.	Breda, L. "Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients." PLoS ONE 7.3 (2012): 1-16.
description	15.	Zalpuri, S. "Red-blood-cell alloimmunization and number of red-blood-cell transfusions." Vox sanguinis 102.2 (2012): 144-149.
description	16.	Bianchi, N. "Involvement of miRNA in erythroid differentiation." Epigenomics 4.1 (2012): 51-65.
description	17.	Hurschler, Benjamin A. "The type II poly(A)-binding protein PABP-2 genetically interacts with the let-7 miRNA and elicits heterochronic phenotypes in Caenorhabditis elegans." Nucleic acids research 39.13 (2011): 5647-57.
description	18.	Denomme, G. "Molecular basis of blood group expression." Transfusion and apheresis science 44.1 (2011): 53-63.
description	19.	Breda, L. "Gene therapy in thalassemia and hemoglobinopathies." Mediterranean Journal of Hematology and Infectious Diseases 1.1 (2009).
description	20.	Hengartner, Michael O. "A quantitative targeted proteomics approach to validate predicted microRNA targets in C. elegans." Nature Methods 7.10 (2010): 837-842.